Company Filing History:
8 out of 1,035 
2 out of 2 
2 out of 49 
Years Active: 2018-2025
Title: Paolo Fiorina: Innovator in Antibody Research
Introduction
Paolo Fiorina is a prominent inventor based in Boston, MA, known for his significant contributions to the field of antibody research. With a total of 10 patents to his name, Fiorina has made remarkable strides in understanding and utilizing antibodies for therapeutic purposes.
Latest Patents
Fiorina's latest patents include groundbreaking inventions related to antibodies and their uses. One notable patent focuses on an antibody or antigen binding fragment that specifically binds to IGFBP3 without displacing the binding of IGF-I to IGFBP3. This invention is crucial as it inhibits or reduces the binding of IGFBP3 to the TMEM219 receptor. Another significant patent involves TMEM219 antibodies, which are designed to bind specifically to the IGFBP3 receptor, TMEM219. This patent also covers methods for their production, pharmaceutical compositions containing these antibodies, and their therapeutic uses.
Career Highlights
Throughout his career, Fiorina has worked with esteemed organizations such as Children's Medical Center Corporation and Enthera S.r.l. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Fiorina has collaborated with notable colleagues, including Andrea Vergani and Francesca D'Addio. These partnerships have fostered a collaborative environment that enhances the research and development of new antibody therapies.
Conclusion
Paolo Fiorina's contributions to antibody research have positioned him as a leading inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in therapeutic applications.